date:Dec 04, 2019
r corrects this deficiency and raises the levels of these important fatty acids in the blood. Increasing the levels of EPA and DHA can help to reduce the fat burden in the liver by improving the livers ability to process excessive pre-existing fat, and at the same time, inhibit the creation of new fat from dietary carbohydrates.
NAFLD has become one of the most common forms of chronic liver disease worldwide. Global prevalence is estimated to be around 20 to 30 percent. Launching Hepacor on the